Projects per year
Personal profile
Headline
PROFESSOR | Genetics and Genomic Sciences
Biography
I am a Genetic Epidemiologist in the Department of Genetics and Genomic Sciences. I have extensive experience in designing studies aimed to identify genetic risk factors associated with complex diseases, such as type 2 diabetes, obesity, cardiovascular disease and Crohn’s disease, as well as with response to therapeutic and lifestyle interventions. Multi-Disciplinary Training Areas Clinical Research Education Program [CLR], Genetics and Genomic Sciences [GGS] Education MSc, Tel Aviv University PhD, Tel Aviv University Tufts University Weizmann Institute of Science
Fingerprint
Dive into the research topics where Inga Peter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Molecular and Cellular Basis of the Gut-Brain Axis in Parkinsons Disease
Yue, Z. Z., Han, W., Peter, I., Peter, I., Saunders-pullman, R. R., Saunders-Pullman, R., Han, W. W. & Yue, Z.
National Institute of Neurological Disorders and Stroke
15/09/21 → 31/08/23
Project: Research
-
Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies
Peter, I., Crane, H. M., Crane, H. H. M. & Peter, I.
National Human Genome Research Institute
10/09/19 → 30/06/23
Project: Research
-
17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
International Parkinson’s Disease Genomics Consortium (IPDGC), Dec 2022, In: Molecular Neurodegeneration. 17, 1, 48.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study
Shelton, B. A., Sawinski, D., MacLennan, P. A., Lee, W., Wyatt, C., Nadkarni, G., Fatima, H., Mehta, S., Crane, H. M., Porrett, P., Julian, B., Moore, R. D., Christopoulos, K., Jacobson, J. M., Muller, E., Eron, J. J., Saag, M., Peter, I. & Locke, J. E., Nov 2022, In: eClinicalMedicine. 53, 101653.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)
COLORS in IBD group investigators, Oxford IBD cohort study investigators, INTERVAL Study, Swiss IBD Cohort Investigators, UK IBD Genetics Consortium & NIDDK IBD Genetics Consortium, Dec 2022, In: Nature Communications. 13, 1, 3576.Research output: Contribution to journal › Comment/debate
Open Access -
Breastfeeding Is Associated with Lower Likelihood of Helicobacter Pylori Colonization in Babies, Based on a Prospective USA Maternal-Infant Cohort
Shah, S. C., Tarassishin, L., Eisele, C., Rendon, A., Debebe, A., Hawkins, K., Hillenbrand, C., Agrawal, M., Torres, J., Peek, R. M., Stone, J., Dubinsky, M., Colombel, J. F., Peter, I. & Hu, J., Nov 2022, In: Digestive Diseases and Sciences. 67, 11, p. 5149-5157 9 p.Research output: Contribution to journal › Article › peer-review
-
Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14th century
Waldman, S., Backenroth, D., Harney, É., Flohr, S., Neff, N. C., Buckley, G. M., Fridman, H., Akbari, A., Rohland, N., Mallick, S., Olalde, I., Cooper, L., Lomes, A., Lipson, J., Cano Nistal, J., Yu, J., Barzilai, N., Peter, I., Atzmon, G., Ostrer, H., & 12 others, 8 Dec 2022, In: Cell. 185, 25, p. 4703-4716.e16Research output: Contribution to journal › Article › peer-review
Open Access
Press / Media
-
Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins
30/11/22
1 item of Media coverage
Press/Media
-
-
WHAT WE FUND: $19.7 MILLION IN NEW GRANTS FOR PARKINSON'S RESEARCH
28/12/20
1 item of Media coverage
Press/Media
-
HIGHLIGHTS FROM OUR 13TH PARKINSON'S DISEASE THERAPEUTICS CONFERENCE
25/10/19
1 item of Media coverage
Press/Media
-
Virtual repurposing can speed the discovery of new uses for existing drugs
14/01/19
1 item of Media coverage
Press/Media